Suven Pharmaceuticals Ltd share price logo

Suven Pharmaceuticals Ltd Share Price (SUVENPHAR)

₹664.60.06%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Overview of Suven Pharmaceuticals Ltd

Key events for Suven Pharmaceuticals Ltd

  • US FDA Approves Suven Pharma's Hyderabad Units - 23 Feb, 2024

    Suven Pharmaceuticals has received approval from the US Food & Drug Administration for its Active Pharmaceutical Ingredients and Formulations facilities in Hyderabad, India. The successful completion of pre-approval and good manufacturing practices inspections is a positive development for the company.

  • Suven Pharma Shares Plunge After Weak Q3 Earnings - 06 Feb, 2024

    Suven Pharmaceuticals Ltd's Q3 net profit grew 56.6% YoY to Rs 46.8 crore, but its revenue dropped nearly 38%. The company's weak bottom line along with forex losses in the quarter also dragged its operational performance in Q3. Suven Pharma shares plunged 10% after weak Q3 earnings on all three key parameters of net profit, revenue, and profitability. The stock lost 5.98% to close at Rs 612.25.

  • Suven Pharma Reports Mixed Results for Q2 and Q3 FY24 - 05 Feb, 2024

    Suven Pharmaceuticals reported a 10% YoY rise in consolidated net profit for Q2 FY24 but a 56.6% YoY fall in Q3 FY24. The company's CEO remains confident about achieving medium-term growth despite near-term softness.

Analyst Rating for Suven Pharmaceuticals Ltd stock

based on 1 analysts

BUY
100.00%
Buy
0.00%
Hold
0.00%
Sell

Based on 1 analysts offering long term price targets for Suven Pharmaceuticals Ltd. An average target of ₹710

Source: S&P Global Market Intelligence

Suven Pharmaceuticals Ltd share Performance

  • ₹658
    ₹669.95
    ₹664.6
    downward going graph

    0.99%

    Downside

    Day's Volatility:1.80%

    Upside

    0.80%

    downward going graph
  • ₹463.3
    ₹768
    ₹664.6
    downward going graph

    30.29%

    Downside

    52 Weeks Volatility:45.85%

    Upside

    15.56%

    downward going graph
1 Month Return-3 %
3 Month Return7.99 %
1 Year Return38.04 %
Previous Close₹665.00
Open₹668.30
Volume3.78L
Market Cap₹16,928.57Cr

Suven Pharmaceuticals Ltd Company Information

Suven Pharmaceuticals Limited (SPL) is a biopharmaceutical company engaged in the development and manufacturing of New Chemical Entity (NCE) based Intermediates and Active Pharmaceutical Ingredients, Speciality Chemicals, and formulated drugs. In 2019, Suven Life Sciences Ltd. transferred the CRAMS business to the Company, and the equity shares of the Company were listed for trading in March 2020. The Board approved and recommended the issue of 1:1 bonus shares in August 2020, and the number of shares increased from 127,282,478 to 254,564,956. In 2021, Suven invested 120 crore in investing and has a capex plan of Rs.320crore. In 2022, the Company also filed 17 ANDAs for which 9 were approved and 8 products were launched. The Company acquired 100 stake in Casper Pharma Private Limited in 2022, making it a Wholly Owned Subsidiary. In this way, Suven Pharmaceuticals Limited is endeavouring to be the leading biopharmaceutical company in global markets.

Share Price: ₹664.60 per share as on 23 Feb, 2024 04:01 PM
Market Capitalisation: ₹16,928.57Cr as of today
Revenue: ₹219.82Cr as on December 2023 (Q4 23)
Net Profit: ₹46.75Cr as on December 2023 (Q4 23)
Listing date: 05 Mar, 2020
Chairperson Name: J V Ramudu
OrganisationSuven Pharmaceuticals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Suven Pharmaceuticals Ltd

Insights on Suven Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.15% to 13.40% in Dec 2023 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 10.01% to 10.14% in Dec 2023 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, SUVENPHAR stock has moved up by 37.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 60.9% return, outperforming this stock by 22.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 159.6% return, outperforming this stock by 121.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 60.00% of holdings in Dec 2023 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 380.76 Cr → 234.16 Cr (in ₹), with an average decrease of 14.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 123.97 Cr → 46.75 Cr (in ₹), with an average decrease of 26.0% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.84% to 13.91% in Dec 2023 quarter

Suven Pharmaceuticals Ltd Valuation

Suven Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (4.48x)

March 30, 2020

Today (45.58x)

February 23, 2024

Industry (61.84x)

February 23, 2024

Highest (51.50x)

January 4, 2024

LowHigh

Suven Pharmaceuticals Ltd Mutual Fund Holdings

Funds Holdings
UTI Flexi Cap Fund - Growth Option - DirectUTI Flexi Cap Fund - Growth Option - Direct1.26%
DSP Healthcare Fund Direct GrowthDSP Healthcare Fund Direct Growth8.06%
HSBC Small Cap Fund Fund Direct GrowthHSBC Small Cap Fund Fund Direct Growth1.11%
DSP ELSS Tax Saver Fund Direct Plan GrowthDSP ELSS Tax Saver Fund Direct Plan Growth1.01%
Tata Small Cap Fund Direct GrowthTata Small Cap Fund Direct Growth2.2%

Suven Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
60%
0.00
Foreign Institutions
10.14%
1.26
Mutual Funds
13.4%
10.27
Retail Investors
13.91%
-12.18
Others
2.55%
27.82

Technicals of Suven Pharmaceuticals Ltd share

News & Events of Suven Pharmaceuticals Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Suven Pharmaceuticals Ltd shares.

Suven Pharmaceuticals Ltd (SUVENPHAR) share price today is ₹664.6

Suven Pharmaceuticals Ltd is listed on NSE

Suven Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of Suven Pharmaceuticals Ltd is ₹669.95.
  • Today’s lowest price of Suven Pharmaceuticals Ltd is ₹658.

PE Ratio of Suven Pharmaceuticals Ltd is 45.58

PE ratio = Suven Pharmaceuticals Ltd Market price per share / Suven Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Suven Pharmaceuticals Ltd(SUVENPHAR) is 3.78L.

Today’s market capitalisation of Suven Pharmaceuticals Ltd(SUVENPHAR) is ₹16928.57Cr.

Suven Pharmaceuticals Ltd(SUVENPHARPrice
52 Week High
₹768
52 Week Low
₹463.3

Suven Pharmaceuticals Ltd(SUVENPHAR) share price is ₹664.6. It is down -13.46% from its 52 Week High price of ₹768

Suven Pharmaceuticals Ltd(SUVENPHAR) share price is ₹664.6. It is up 43.45% from its 52 Week Low price of ₹463.3

Suven Pharmaceuticals Ltd(SUVENPHARReturns
1 Day Returns
-0.4%
1 Month Returns
-3%
3 Month Returns
7.99%
1 Year Returns
38.04%